AHI perspectives: flexible drug labeling and its impact on the drug development process. Practicality of clinical development.
Copeland
D D
DD
Bayer Corporation, Merriam, KS 66202, USA.
D000818:Animals; D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000592:standards*; D004345:Drug Industry / Q000191:economics; D004348:Drug Labeling; D014481:United States; D014730:Veterinary Medicine
D000890:Anti-Infective Agents